Dr Diana Rubel will review malignancy risk in psoriatic patients (inherent and associated with traditional and biologic therapies), with recommendations for management.
Malignancy Risk and Management in Psoriatic Patients

Dr Diana Rubel will review malignancy risk in psoriatic patients (inherent and associated with traditional and biologic therapies), with recommendations for management.
Monday: 8am – 6pm
Tuesday: 8am – 6pm
Wednesday: 8am – 6pm
Thursday: 8am – 5pm
Friday: 8am – 5pm